Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 31% ± 18% | |
basal cell | 3 studies | 22% ± 5% | |
dendritic cell | 3 studies | 25% ± 4% |
Insufficient scRNA-seq data for expression of PAK1IP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 682.83 | 180 / 180 | 100% | 56.22 | 430 / 430 |
prostate | 100% | 3097.45 | 245 / 245 | 100% | 146.83 | 502 / 502 |
esophagus | 100% | 885.95 | 1444 / 1445 | 100% | 50.03 | 183 / 183 |
breast | 100% | 905.32 | 459 / 459 | 100% | 51.44 | 1114 / 1118 |
intestine | 100% | 710.18 | 964 / 966 | 100% | 52.55 | 526 / 527 |
bladder | 100% | 844.43 | 21 / 21 | 100% | 53.61 | 502 / 504 |
brain | 100% | 646.31 | 2631 / 2642 | 100% | 48.00 | 705 / 705 |
uterus | 100% | 827.25 | 170 / 170 | 99% | 62.05 | 456 / 459 |
stomach | 100% | 542.76 | 358 / 359 | 99% | 49.26 | 284 / 286 |
thymus | 100% | 713.74 | 652 / 653 | 99% | 32.88 | 600 / 605 |
pancreas | 99% | 467.02 | 326 / 328 | 99% | 31.70 | 176 / 178 |
lung | 97% | 685.37 | 559 / 578 | 100% | 56.79 | 1155 / 1155 |
skin | 100% | 1076.06 | 1807 / 1809 | 96% | 75.20 | 455 / 472 |
liver | 100% | 527.09 | 225 / 226 | 96% | 29.51 | 391 / 406 |
adrenal gland | 100% | 849.24 | 258 / 258 | 96% | 29.04 | 220 / 230 |
kidney | 100% | 529.64 | 89 / 89 | 92% | 23.21 | 827 / 901 |
adipose | 100% | 994.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.35 | 29 / 29 |
spleen | 100% | 718.05 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.55 | 1 / 1 |
muscle | 100% | 752.77 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 634.91 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 516.77 | 835 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 25.24 | 60 / 80 |
peripheral blood | 49% | 513.21 | 457 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060021 | Biological process | roof of mouth development |
GO_0042273 | Biological process | ribosomal large subunit biogenesis |
GO_0008283 | Biological process | cell population proliferation |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0005730 | Cellular component | nucleolus |
GO_0005515 | Molecular function | protein binding |
Gene name | PAK1IP1 |
Protein name | PAK1 interacting protein 1 isoform 4 (PAK1 interacting protein 1, isoform CRA_c) PAK1 interacting protein 1 isoform 1 p21-activated protein kinase-interacting protein 1 (PAK/PLC-interacting protein 1) (hPIP1) (PAK1-interacting protein 1) (WD repeat-containing protein 84) |
Synonyms | hCG_1782977 WDR84 PIP1 |
Description | FUNCTION: Negatively regulates the PAK1 kinase. PAK1 is a member of the PAK kinase family, which has been shown to play a positive role in the regulation of signaling pathways involving MAPK8 and RELA. PAK1 exists as an inactive homodimer, which is activated by binding of small GTPases such as CDC42 to an N-terminal regulatory domain. PAK1IP1 also binds to the N-terminus of PAK1, and inhibits the specific activation of PAK1 by CDC42. May be involved in ribosomal large subunit assembly . . |
Accessions | A0A0S2Z5C3 Q9NWT1 ENST00000379568.4 ENST00000644756.2 A0A0S2Z5D3 |